Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEGeneral UpdatesResults2 Sept 2026

Persistent Systems Limited

General Updates

Persistent Systems Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015, regarding the Board of Directors' meeting held on September 2, 2026, where they considered and approved proposals for alteration of the Articles of Association, long-term debt financing, and fund raising.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A2 Sept 2026

RPG Life Sciences Limited

Press Release

RPG Life Sciences Limited's wholly owned subsidiary, RPG Active Pharma Limited, has acquired the Active Pharmaceutical Ingredients (API) and Intermediates business undertaking of Raghava Life Sciences Private Limited for up to ₹135 crore. The acquisition strengthens RPG Active Pharma's integrated API play and adds approximately 300 KL of installed capacity in a state-of-the-art EU-GMP approved plant and a portfolio of 22 commercialized APIs plus 7 under development.

Read more →📎 1 attachment
NSEGeneral UpdatesDivestiture2 Sept 2026

RPG Life Sciences Limited

General Updates

RPG Life Sciences Limited's wholly owned subsidiary, RPG Active Pharma Limited, has entered into a Business Transfer Agreement with Raghava Life Sciences Private Limited to acquire its Active Pharmaceutical Ingredients (APIs) and intermediates businesses on a going concern basis through a slump sale.

Read more →📎 1 attachment
NSEOutcome of Board MeetingFundraise2 Sept 2026

Persistent Systems Limited

Outcome of Board Meeting

Persistent Systems Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026, where the Board of Directors approved proposals for alteration of Articles of Association, long-term debt financing, and fund raising through various instruments.

Read more →📎 1 attachment
NSEShareholders meetingResults2 Sept 2026

IDFC First Bank Limited

Shareholders meeting

IDFC First Bank Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 31, 2026, and informed the Exchange regarding voting results.

Read more →📎 1 attachment
NSEUpdatesESG2 Sept 2026

Religare Enterprises Limited

Updates

Religare Enterprises Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company▲ PositiveLitigation2 Sept 2026

Nuvama Wealth Management Limited

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Nuvama Wealth Management Limited has informed the Exchange about an update on material litigation, where Nuvama Clearing Services Limited, a wholly owned material subsidiary, has received a favorable judgment from the Hon'ble Supreme Court with respect to a long-standing material litigation.

Read more →📎 1 attachment
NSEGeneral UpdatesM&A2 Sept 2026

RPG Life Sciences Limited

General Updates

RPG Life Sciences Limited has announced the execution of a Business Transfer Agreement by its wholly owned subsidiary, RPG Active Pharma Limited, with Raghava Life Sciences Private Limited for the acquisition of Active Pharmaceutical Ingredients (APIs) and intermediates Businesses as a going concern, by way of slump sale.

Read more →📎 1 attachment
NSEShareholders meetingResults2 Sept 2026

Religare Enterprises Limited

Shareholders meeting

Religare Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026. The meeting will be held through Video Conferencing / Other Audio Visual Means (VC/OAVM) to transact the following businesses: adoption of audited standalone financial statements, adoption of audited consolidated financial statements, re-designation of Mr. Arjun Lamba as the Managing Director, and approval of the re-designation of Mr. Arjun Lamba.

Read more →📎 1 attachment
NSEUpdatesESG2 Sept 2026

Aarti Drugs Limited

Updates

Aarti Drugs Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26, as required by SEBI regulations.

Read more →📎 1 attachment
NSEGeneral Updates2 Sept 2026

Ashoka Buildcon Limited

General Updates

Ashoka Buildcon Limited has informed the Exchange about Intimation about Book Closure dates for the 33rd Annual General Meeting (AGM) scheduled to be held on September 25, 2026.

Read more →📎 1 attachment
NSEShareholders meetingResults2 Sept 2026

Aarti Drugs Limited

Shareholders meeting

Aarti Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026, along with the Annual Report for the Financial Year 2025-26.

Read more →📎 1 attachment
← PreviousPage 444 of 2781Next →